(3.210.184.142) 您好!臺灣時間:2021/05/09 09:31
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

: 
twitterline
研究生:林聖興
研究生(外文):Sheng-Shing Lin
論文名稱:中西藥交互作用資訊網站之建構
論文名稱(外文):Constructing a Web Site for Drug-Herb Interaction
指導教授:陳方周陳方周引用關係張恒鴻張恒鴻引用關係
指導教授(外文):Fun-jou ChenHen-Hong Chang
學位類別:碩士
校院名稱:中國醫藥大學
系所名稱:中西醫結合研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2005
畢業學年度:94
語文別:中文
論文頁數:168
中文關鍵詞:中西藥併用交互作用網站
外文關鍵詞:herbdruginteractionweb site
相關次數:
  • 被引用被引用:6
  • 點閱點閱:605
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:118
  • 收藏至我的研究室書目清單書目收藏:4
本研究之目的在於建構一個中西藥交互作用資訊網站,讓中醫師、西醫師、藥師能夠即時查閱,對患者有所助益。
搜尋PubMed以及國家圖書館網站有關中西藥併用的期刊與博碩士論文,擷取相關文字片段,建立MySQL資料庫,使用PHP語言設計網頁搜尋引擎。操作者可在中藥、西藥欄位分別輸入文字,查詢到交互作用資訊,並可點按網頁超連結直接瀏覽原文出處網站。在接受查詢時,記錄每一筆輸入的中藥、西藥名稱,供日後統計最常被查詢的中西藥組合。
總共分析147篇國內外醫學文獻,摘錄中西藥交互作用共481筆資料,中草藥與西藥的組合共219種。銀杏葉、人參、麻黃、金絲桃草(St. John’s wort)、甘草、丹參為被報導最多的中草藥。而臨床證實最多的是金絲桃草與Cyclosporin間的交互作用。
現有的中西藥交互作用文獻中,大多討論不良反應,僅有少數篇章談到中西藥併用的優點。不良反應若來自併服中藥造成西藥的血中濃度升高,可考慮採用低劑量的西藥,發揮中西藥併用的優點,但必須先建立藥物動力學模式,有待專業人員進一步研究,現階段宜注意不良反應。
In order to provide the convenience for the clinical knowledge about combination use of Chinese herbs and modern medication, this study is aimed to construct a web site offering comprehensive information on drug-herb interaction.
We searched journals from the PubMed websites as well as the dissertations and theses published in Taiwan with the topic of drug-herb interactions, and finally 147 articles totally been reviewed. Among these articles, there were 219 different kinds of drug-herb combinations in 481 records about drug-herb interaction. The most commonly described herbs were Ginkgo, Ginseng, Ma Huang, St. John’s wort, Licorice, and Dan Shen. We constructed a database which classified these data with the columns of the names of the drugs (both in Chinese and English), interaction and so forth. Subsequently, we designed a web page to present this database.
Nevertheless, the usages of herbs in western countries is quite different from those in Taiwan. Herb is made in single form in the United States, while the traditional Chinese doctors prescribe composition of multiple herbs in Taiwan. The web site constructed in this study does not offer the validation of the drug-herb interactions because it needs further check in detail.
The adverse reactions of drug-herb interactions mentioned in the international journals are worthy to beware. Further study is necessary to discuss the advantage and disadvantage of the integration of Chinese and western medicine.
第一章 前言 1
第一節、研究背景 1
第二節、研究目的 5
第二章 文獻探討 6
第一節、中藥與中藥之間的交互作用 6
第二節、西藥與西藥之間的交互作用 7
第三節、中藥與西藥之間的交互作用 9
第三章 材料與方法 10
第一節、資料收集 10
第二節、資料庫的建立方法 12
第三節、網站資料庫建立及網頁設計 14
第四節、專家諮詢會議 15
第四章 結果 16
第一節、資料收集 16
第二節、資料擷取結果 18
第三節、網站資料庫建立及網頁設計 24
第四節、網站資料庫的內容 34
第五節、專家會議結果 136
第五章 討論 140
第一節、藥物的使用 140
第二節、方法的設計 143
第三節、相似網站之比較 147
第四節、網站技術可行的後續發展 151
第五節、網站資料庫將來的應用 153
第六章 結論 155
參考文獻 157
附  錄 163
英文摘要 165
作者簡歷 166
謝  辭 168
1.Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165(10):1095-1106.
2.李珮端:臺灣中部地區中西藥物併用之概況調查。行政院衛生署中醫藥年報 2003;21(1):413-459.
3.朱和翔、陳緋娜、林正介、蔡文正:中西藥物服用行為之分析 - 以中部某醫學中心門診病患為例。中國醫藥學院醫務管理研究所; 2003, 91CMCH0528027.
4.張賢哲:本草備要解析。中國醫藥大學出版組,台中市,1994; 725-726.
5.廖志飛, 何禮剛, 楊行義:最新人體藥理學。合記圖書出版社,台北市,2000; 35-46.
6.Hare C, Halligan S, Bartram CI, Platt K, Raleigh G. Cisapride or metoclopramide to accelerate small bowel transit during barium follow-through examination? Abdom Imaging 2000;25(3):243-245.
7.Joffe HV, Xu R, Johnson FB, Longtine J, Kucher N, Goldhaber SZ. Warfarin dosing and cytochrome P450 2C9 polymorphisms. Thromb Haemost 2004;91(6):1123-1128.
8.Zhang J, Ha PT, Lou Y, Hoogmartens J, Van Schepdael A. Kinetic study of cytochrome P450 3A4 activity on warfarin by capillary electrophoresis with fluorescence detection. J Chromatogr A 2005;1082(2):235-239.
9.Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions. Pharmacoepidemiol Drug Saf 2005;14(11):755-767.
10.Youlten L. The effect of repeat dosing with cimetidine on the pharmacokinetics of intravenous granisetron in healthy volunteers. J Pharm Pharmacol 2004;56(2):169-175.
11.Tokairin T, Fukasawa T, Yasui-Furukori N, Aoshima T, Suzuki A, Inoue Y, et al. Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism. Br J Clin Pharmacol 2005;60(2):172-175.
12.Djordjevic D, Nikolic J, Stefanovic V. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens. Pathol Biol (Paris) 1998;46(10):760-770.
13.Shin JG, Park JY, Kim MJ, Shon JH, Yoon YR, Cha IJ, et al. Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos 2002;30(10):1102-1107.
14.Johne A, Perloff ES, Bauer S, Schmider J, Mai I, Brockmoller J, et al. Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers. Eur J Clin Pharmacol 2004;60(9):617-622.
15.Ejiri N, Katayama K, Doi K. Induction of cytochrome P450 isozymes by phenobarbital in pregnant rat and fetal livers and placenta. Exp Mol Pathol 2005;78(2):150-155.
16.Bhaloo S, Prasad GV. Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report. Transplant Proc 2003;35(7):2449-2451.
17.Alexander BD, Wingard JR. Study of renal safety in amphotericin B lipid complex-treated patients. Clin Infect Dis 2005;40 Suppl 6:S414-421.
18.Gronroos M, Chen M, Jahnukainen T, Capitanio A, Aizman RI, Celsi G. Methotrexate induces cell swelling and necrosis in renal tubular cells. Pediatr Blood Cancer 2005.
19.Hung CC, Guh JY, Kuo MC, Lai YH, Chen HC. Gentamicin-induced diffuse renal tubular dysfunction. Nephrol Dial Transplant 2005.
20.Barone GW, Gurley BJ, Ketel BL, Abul-Ezz SR. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001;71(2):239-241.
21.Bauer S, Stormer E, Johne A, Kruger H, Budde K, Neumayer HH, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 2003;55(2):203-211.
22.Chan TY. Interaction between warfarin and danshen (Salvia miltiorrhiza). Ann Pharmacother 2001;35(4):501-504.
23.Page RL, 2nd, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999;19(7):870-876.
24.Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001;61(15):2163-2175.
25.Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002;25(5):323-344.
26.Miller LG. Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158(20):2200-2211.
27.Cheng TO. Herbal interactions with cardiac drugs. Arch Intern Med 2000;160(6):870-871.
28.Mai I, Bauer S, Perloff ES, Johne A, Uehleke B, Frank B, et al. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction. Clin Pharmacol Ther 2004;76(4):330-340.
29.Lo AC, Chan K, Yeung JH, Woo KS. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats. Eur J Drug Metab Pharmacokinet 1992;17(4):257-262.
30.葉怡柔、李珮端、徐素蘭:葛根之代謝動力學及其對環孢靈、地高辛動力學之影響。中國醫藥大學中國藥學研究所; 2002, 90CMCH0049012.
31.游明謙:中藥麥門冬湯與西藥併用治療氣喘之交互作用研究。行政院衛生署中醫藥年報 2004;22(5):207-226.
32.Gupta D, Jalali M, Wells A, Dasgupta A. Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate. J Clin Lab Anal 2002;16(6):290-294.
33.Awang DV, Fugh-Berman A. Herbal interactions with cardiovascular drugs. J Cardiovasc Nurs 2002;16(4):64-70.
34.Rogers EA, Gough JE, Brewer KL. Are emergency department patients at risk for herb-drug interactions? Acad Emerg Med 2001;8(9):932-934.
35.Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 2003;167(2):367.
36.Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46(6):1775-1776.
37.Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 2003;10(3):163-169.
38.Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician 2003;68(8):1539-1542.
39.Shaw HS, Kroll DJ. The convergence of herb pharmacodynamics and herb-drug interactions on hemostasis. Altern Ther Health Med 2001;7(6):46-47.
40.Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54(6):692-693.
41.McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Cmaj 1996;155(3):293-295.
42.Mai I, Kruger H, Budde K, Johne A, Brockmoller J, Neumayer HH, et al. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther 2000;38(10):500-502.
43.Ruschitzka F, Meier PJ, Turina M, Luscher TF, Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet 2000;355(9203):548-549.
44.Karliova M, Treichel U, Malago M, Frilling A, Gerken G, Broelsch CE. Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000;33(5):853-855.
45.Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66(4):338-345.
46.Barbenel DM, Yusufi B, O'Shea D, Bench CJ. Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline. J Psychopharmacol 2000;14(1):84-86.
47.Cheng KF, Leung KS, Leung PC. Interactions between modern and Chinese medicinal drugs: a general review. Am J Chin Med 2003;31(2):163-169.
48.Kuhn MA. Herbal remedies: drug-herb interactions. Crit Care Nurse 2002;22(2):22-28, 30, 32; quiz 34-25.
49.Tam LS, Chan TY, Leung WK, Critchley JA. Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Aust N Z J Med 1995;25(3):258.
50.Izzat MB, Yim AP, El-Zufari MH. A taste of Chinese medicine! Ann Thorac Surg 1998;66(3):941-942.
51.李珮端:中藥西藥交互作用之隱憂與開發前景。生物醫學報導 2001;7:16-17.
52.王孟珠、蔡尚元、李珮端、徐素蘭:柚皮甙吸收之改善及含柚皮甙中藥對環孢靈動力學之影響。中國醫藥大學中國藥學研究所; 2002, 90CMCH0049015.
53.高百源:葡萄柚汁和藥品間的交互作用。 臺北市藥師公會會刊 1996;14(5):47-51.
54.何虂菁、李珮端、徐素蘭:三黃瀉心湯之代謝動力學及其對環孢靈動力學之影響。中國醫藥大學中國藥學研究所; 2004, 92CMCH0049012.
55.賴英秀、黃怡超:中藥和西藥能夠併用嗎? 當代醫學 2001;28(2):34-37.
56.Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am J Gastroenterol 2001;96(5):1654-1655.
57.Hutchins GM. Ma huang toxicity. Mayo Clin Proc 2002;77(7):733.
58.Skoulidis F, Alexander GJ, Davies SE. Ma huang associated acute liver failure requiring liver transplantation. Eur J Gastroenterol Hepatol.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔